Latest Drugs Stories
Increased Competition Lowers Drug Costs Washington D.C.
Increased Competition Lowers Drug Costs WASHINGTON, Jan.
Today, NCPDP addressed the FDA, CDER and ODAC meeting that met to review and make a recommendation on what may be the first biosimilar to receive FDA approval in the U.S., and potentially develop
The Report OTC Market in Central Europe 2014 Comparative analysis and development forecasts for 2014-2019 provides information on pricing, market analysis, shares, forecast, and company profiles
New research reveals nearly 60% of patients using opioid painkillers are combining multiple prescriptions with potentially serious safety risks; Novus Medical Detox Center calls for stricter monitoring
QUÉBEC CITY, Dec. 29, 2014 /PRNewswire/ - Aeterna Zentaris Inc.
New report from Kantar Health shows opportunities for biosimilars are high in oncology, low in rheumatoid arthritis in China. Shanghai, China (PRWEB) December
In light of a recent study demonstrating the connection between adolescents' use of anti-anxiety and sleep medications and subsequent prescription drug abuse, Novus Medical Detox Center calls for parental
- Stoppage; cessation (of labor).
- A standing still or idling (of mills, factories, etc.).